In some animal studies, early-life hypermethylation of the IGFBP2 promoter and reduced IGFBP2 expression were linked to disrupted glucose regulation, obesity, and liver fat accumulation later in life [57]. The gene discussed is IGFBP2; the disease is obesity due to melanocortin 4 receptor deficiency.